Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CarryGenes Oncology AB
AB
Active
Org 5591961890
Rörstrandsgatan 58, 113 40
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CarryGenes Oncology AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SL
Sven Lennart Dreyer
Chief Executive Officer
Chief Executive Officer
2023
Former (2)
TD
Thijs Dirkse
Chief Executive Officer
Chief Executive Officer
2020 – 2022
SO
Stig Ola Winqvist
Chief Executive Officer
Chief Executive Officer
2020 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DG
Derek Gregory Batcheller
Chairman
2023
MS
Michael Sven Rohmann
Board of Directors
2023
Former (6)
UL
Ulf Lennart Holm
Board of Directors
2020 – 2023
AG
Amy Greene
Board of Directors
2022 – 2024
HO
Hans Olof Glise
Chairman
2020 – 2020
DG
Derek Gregory Batcheller
Chairman
2020 – 2022
LS
Lars-Gunnar Stefan Appelgren
Board of Directors
2022 – 2023
EL
Edward Leon Perkins
Board of Directors
2020 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
CarryGenes Holding Kommanditbolag
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CarryGenes Oncology AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network